Sonidegib Efficacy and Safety in Patients with Locally Advanced Basal Cell Carcinoma Based on Tumor Aaggressiveness Main Article Content Michael R Migden Reinhard Dummer Keywords sonidegib, basal cell carcinoma, non-melanoma skin cancer, skin cancer Abstract Abstract Not Available Article Sidebar Poster PDF Published Oct 27, 2017 DOI https://doi.org/10.25251/skin.1.supp.119 Article Details How to Cite Migden, M. R., & Dummer, R. (2017). Sonidegib Efficacy and Safety in Patients with Locally Advanced Basal Cell Carcinoma Based on Tumor Aaggressiveness. SKIN The Journal of Cutaneous Medicine, 1(3.1), s120. https://doi.org/10.25251/skin.1.supp.119 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Issue Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas Section Non-Melanoma Skin Cancers and Benign Cutaneous Tumors This work is licensed under a Creative Commons Attribution 4.0 International License. Authors transfer copyright to the publisher as part of the journal publishing agreement.All reprints are subject to the reprint policy.